NICE has published draft guidance restricting use of antibiotics in patients with chronic obstructive pulmonary disease (COPD), as in many cases the treatment is inappropriate and could lea
The UK's NICE endorsed regular NHS funding for big-selling drugs from Roche and Sanofi, changing its mind in guidance for the multiple sclerosis and eczema drugs.
UK patients are stepping up efforts to resolve the “heartbreaking” row that is denying their families access to Vertex’s groundbreaking cystic fibrosis (CF) drug Orkambi, after Sweden becam